Evidence map›Paper›PMID 33673250›Full record

ArticleInternational journal of environmental research and public health2021

A Novel Score for Predicting Alzheimer's Disease Risk from Late Life Psychopathological and Health Risk Factors.

Javier Santabárbara, Juan Bueno-Notivol, Darren M Lipnicki, Concepción de la Cámara, Raúl López-Antón, Antonio Lobo, Patricia Gracia-García

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Javier SantabárbaraDepartment of Preventive Medicine and Public Health, Universidad de Zaragoza, 50001 Zaragoza, Spain.ORCID 0000-0002-7297-6104
Juan Bueno-NotivolPsychiatry Service, Hospital Universitario Miguel Servet, 50009 Zaragoza, Spain.ORCID 0000-0002-0519-4962
Darren M LipnickiCentre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales Medicine, 2052 Randwick, Australia.ORCID 0000-0002-1684-3577
Concepción de la CámaraInstituto de Investigación Sanitaria de Aragón (IIS Aragón), 50001 Zaragoza, Spain.
Raúl López-AntónInstituto de Investigación Sanitaria de Aragón (IIS Aragón), 50001 Zaragoza, Spain.
Antonio LoboInstituto de Investigación Sanitaria de Aragón (IIS Aragón), 50001 Zaragoza, Spain.
Patricia Gracia-GarcíaInstituto de Investigación Sanitaria de Aragón (IIS Aragón), 50001 Zaragoza, Spain.
Universidad de Zaragoza · ESHospital Universitario Miguel Servet · ESUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the increasing size of the aging population, dementia risk reduction has become a main public health concern. Dementia risk models or indices may help to identify individuals in the community at high risk to develop dementia. We have aimed to develop a novel dementia risk index focused on the late-life (65 years or more) population, that addresses risk factors for Alzheimer's disease (AD) easily identifiable at primary care settings. These risk factors include some shown to be associated with the risk of AD but not featured in existing indices, such as hearing loss and anxiety. Our index is also the first to account for the competing risk of death. The Zaragoza Dementia and Depression Project (ZARADEMP) Alzheimer Dementia Risk Score predicts an individual´s risk of developing AD within 5 years. The probability of late onset AD significantly increases in those with risk scores between 21 and 28 and, furthermore, is almost 4-fold higher for those with risk scores of 29 or higher. Our index may provide a practical instrument to identify subjects at high risk of AD and to design preventive strategies targeting the contributing risk factors.

Indexed as

Alzheimer DiseaseAgedAgingAnxietyAnxiety DisordersHumansRisk Factorscompeting riskdementiapsychopathological risk factorsrisk indexZARADEMP

Identifiers

PMID33673250
PMCPMC7918511
OpenAlexW3131494336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.